Does day 11 omission of methotrexate due to toxicity influence the outcome in myeloablative hematopoietic cell transplant? Results from a single-center retrospective cohort study

Blood Cancer J. 2015 Aug 28;5(8):e344. doi: 10.1038/bcj.2015.70.

¹ Bone Marrow Transplant Program, Department of Hematology & Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, USA.
² Quantitative Health Sciences, Cleveland Clinic Lerner Research Institute, Cleveland, OH, USA.
³ Department of Hematology/Oncology, Staten Island University Hospital, New York, NY, USA.
⁴ Department of Pediatric Hematology & Oncology, Cleveland Clinic, Cleveland, OH, USA.
⁵ Levine Cancer Institute, Carolinas HealthCare System, Charlotte, NC, USA.

No abstract available

Publication types